NADAC acquisition cost data for MOTION SICKNESS 50 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Meclizine HCl |
| Brand Name | Motion Sickness Relief |
| Manufacturer | Kroger Company |
| Dosage Form | TABLET |
| Route | ORAL |
| Pharmacologic Class | Antiemetic |
| Product Type | HUMAN OTC DRUG |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 46122053653 | $0.0620 | 2022-12-21 | OTC |
| 70000040401 | $0.0620 | 2022-12-21 | OTC |
| 46122053653 | $0.0620 | 2022-12-21 | OTC |
| 70000040401 | $0.0620 | 2022-12-21 | OTC |
Generic: Meclizine HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A |
| 2021 | $5.9K | 39 | 29 | $3.57 |
| 2022 | $35.8K | 218 | 177 | $3.44 |
| 2023 | $2.1K | 24 | 23 | $2.45 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.